Huang Qiang, Ying Jun, Yu Wen, Dong Yao, Xiong Hao, Zhang Yiping, Liu Jie, Wang Xifeng, Hua Fuzhou
Department of Anesthesiology, the Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, 330006, Jiangxi, China.
Key Laboratory of Anesthesiology of Jiangxi Province, 1# Minde Road, 330006, Nanchang City, Jiangxi Province, People's Republic of China.
Mol Neurobiol. 2024 May;61(5):2866-2880. doi: 10.1007/s12035-023-03699-9. Epub 2023 Nov 9.
Alzheimer's disease (AD) is a major cause of age-related dementia, which is becoming a global health crisis. However, the pathogenesis and etiology of AD are still not fully understood. And there are no valid treatment methods or precise diagnostic tools for AD. There is increasing evidence that P2X7R expression is upregulated in AD and is involved in multiple related pathological processes such as Aβ plaques, neurogenic fiber tangles, oxidative stress, and chronic neuroinflammation. This suggests that P2X7R may be a key player in the development of AD. P2X7R is a member of the ligand-gated purinergic receptor (P2X) family. It has received attention in neuroscience due to its role in a wide range of aging and age-related neurological disorders. In this review, we summarize current information on the roles of P2X7R in AD and suggest potential pharmacological interventions to slow down AD progression.
阿尔茨海默病(AD)是与年龄相关的痴呆症的主要病因,而痴呆症正成为一场全球健康危机。然而,AD的发病机制和病因仍未完全明确。并且目前尚无针对AD的有效治疗方法或精确诊断工具。越来越多的证据表明,P2X7R在AD中的表达上调,并参与多种相关病理过程,如β淀粉样蛋白(Aβ)斑块、神经原纤维缠结、氧化应激和慢性神经炎症。这表明P2X7R可能在AD的发展过程中起关键作用。P2X7R是配体门控嘌呤能受体(P2X)家族的成员。由于其在多种衰老及与年龄相关的神经疾病中发挥作用,它在神经科学领域受到了关注。在这篇综述中,我们总结了关于P2X7R在AD中作用的当前信息,并提出了减缓AD进展的潜在药物干预措施。